Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

entities : Moderna, inc.    crawled time : 13:30    save search

Arbutus Reports Fourth Quarter and Year End 2021 Financial Results and Provides Corporate Update
Published: 2022-03-03 (Crawled : 13:30) - biospace.com/
ROIV | $10.45 -2.43% -2.49% 4M twitter stocktwits trandingview |
Manufacturing
| | O: -0.64% H: 0.8% C: -7.54%
MRNA | News S | $103.45 -0.33% -0.33% 2M twitter stocktwits trandingview |
Health Technology
| | O: -1.24% H: 0.9% C: -4.31%
ASMB | $12.92 -11.02% -12.38% 27K twitter stocktwits trandingview |
Health Technology
| | O: 1.99% H: 1.3% C: -0.65%
ABUS | $2.79 -4.45% -4.66% 710K twitter stocktwits trandingview |
Health Technology
| | O: -1.28% H: 4.21% C: -4.53%

financial results report results
Moderna to Present at Upcoming Conferences in March 2022
Published: 2022-03-02 (Crawled : 13:30) - biospace.com/
MRNA | News S | $103.45 -0.33% -0.33% 2M twitter stocktwits trandingview |
Health Technology
| | O: -1.93% H: 0.0% C: 0.0%

conference
Moderna Initiates Phase 3 Portion of Pivotal Trial for mRNA Respiratory Syncytial Virus (RSV) Vaccine Candidate, Following Independent Safety Review of Interim Data
Published: 2022-02-22 (Crawled : 13:30) - biospace.com/
MRNA | News S | $103.45 -0.33% -0.33% 2M twitter stocktwits trandingview |
Health Technology
| | O: -2.39% H: 6.28% C: 1.9%

respiratory trial vaccine phase 3
Moderna Expands Its mRNA Pipeline with Three New Development Programs
Published: 2022-02-18 (Crawled : 13:30) - biospace.com/
MRNA | News S | $103.45 -0.33% -0.33% 2M twitter stocktwits trandingview |
Health Technology
| | O: 0.81% H: 2.65% C: -1.23%

program
Moderna to Report Fourth Quarter and Full Year 2021 Financial Results on Thursday, February 24, 2022
Published: 2022-02-03 (Crawled : 13:30) - biospace.com/
MRNA | News S | $103.45 -0.33% -0.33% 2M twitter stocktwits trandingview |
Health Technology
| | O: -3.66% H: 3.05% C: -0.68%

financial results report results
Tessera Therapeutics Adds New Executives to its Leadership Team as the Company Continues to Pioneer Gene Writing™ Technology as New Category in Genetic Medicine
Published: 2021-12-08 (Crawled : 13:30) - biospace.com/
SGMO | $0.513 -5.35% -5.65% 1.2M twitter stocktwits trandingview |
Health Technology
| | O: 2.35% H: 2.94% C: 2.71%
MRNA | News S | $103.45 -0.33% -0.33% 2M twitter stocktwits trandingview |
Health Technology
| | O: 5.2% H: 2.09% C: 0.36%

genetic technology therapeutics
Gainers vs Losers
56% 44%

Top 10 Gainers
INVO | $1.76 131.58% 56.82% 230M twitter stocktwits trandingview |
Health Technology

SINT | $0.0365 59.39% 37.26% 470M twitter stocktwits trandingview |
Health Technology

WISA 4 | $9.19 50.66% 33.7% 65M twitter stocktwits trandingview |
Electronic Technology

EDBL | News | $6.73 47.91% 32.39% 13M twitter stocktwits trandingview |

GCTK | $0.715 36.27% 26.62% 640K twitter stocktwits trandingview |
Manufacturing

TCON | $2.33 36.26% 26.61% 2M twitter stocktwits trandingview |
Health Technology

TIRX | $0.48 6.43% 24.58% 4.8M twitter stocktwits trandingview |

KZIA | $0.38 30.58% 23.42% 300K twitter stocktwits trandingview |
Health Technology

VNDA | News | $5.23 29.14% 22.56% 24M twitter stocktwits trandingview |
Health Technology

ATNF | $1.91 29.05% 22.51% 310K twitter stocktwits trandingview |


Your saved searches
Save your searches and get alerts when important news are released.